Table 1.
Overview of the set of analyzed intertypic recombinants.
| Our Study | Published Data | Total | |||
|---|---|---|---|---|---|
| Methods of Analysis | Full Genome Sequencing | Partial Genome Sequencing | Full Genome Sequencing | Partial Genome Sequencing | |
| Number of isolates | 70 | 28 | 33 | 58 | 189 |
| Number (%) of type 1, type 2, and type 3 isolates | 8 (11), | 2 (7), | 3 (9), | 1 (2), | 14 (8), |
| 30 (43), | 9 (32), | 13 (39), | 26 (45), | 78 (41), | |
| 32 (46) | 17 (61) | 17 (52) | 31 (53) | 97 (51) | |
| Number (%) of VDPV | 5 (7) | ? | 15 (45) | ? | ? |
| Number (%) of Sabin-like strains | 65 (93) | ? | 18 (55) | ? | ? |
| Number (%) of AFP cases | 40 (57) | 20 (71) | 24 (73) | 20 (34) | 104 (55) |
| Number (%) of isolates from patients with other diagnoses | 6 (9) | 4 (14) | 1 (3) | - | 11 (6) |
| Number (%) of isolates from healthy persons | 12 (17) | 1 (4) | 7 (21) | 16 (28) | 36 (19) |
| Number (%) of isolates from sewage | 9 (13) | 3 (11) | 1 (3) | 11 (19) | 24 (13) |
| Number (%) of strains of unknown origin | 3 (4) | - | - | 11 (19) | 14 (7) |
VDPV, vaccine-derived poliovirus; AFP, acute flaccid paralysis.